An impaired IGF pathway engenders insulin resistance or abnormal insulin/IGF response, which also leads to an enhanced metabolic syndrome manifestation such as diabetes, hyperglycemia, hyperlipidemia, and obesity. This evidence concerns the gene IGF1 and metabolic syndrome.